Arrowgrass Capital Partners (US)’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-11,684	Closed	-$4.39M	–	458
2017 Q4	$4.39M	Buy	11,684 +5,812	+99%	+$2.35M	0.1%	321
2017 Q3	$2.63M	Buy	5,872 +811	+16%	+$386K	0.04%	425
2017 Q2	$2.49M	Sell	5,061 -8,793	-63%	-$3.85M	0.04%	458
2017 Q1	$5.37M	Buy	13,854 +7,117	+106%	+$2.64M	0.13%	319
2016 Q4	$2.47M	Buy	6,737 +4,131	+159%	+$1.57M	0.07%	344
2016 Q3	$1.05M	Sell	2,606 -250	-9%	-$100K	0.03%	359
2016 Q2	$997K	Sell	2,856 -1,782	-38%	-$686K	0.02%	343
2016 Q1	$1.67M	Buy	+4,638	New	+$1.91M	0.03%	281
2015 Q4	–	Sell	-264	Closed	-$123K	–	477
2015 Q3	$123K	Buy	+264	New	+$142K	﹤0.01%	436
2015 Q2	–	Hold	0	–	–	–	597
2015 Q1	–	Hold	0	–	–	–	541
2014 Q4	–	Hold	0	–	–	–	489
2014 Q3	–	Hold	0	–	–	–	398